Pharmacology of adapalene - PubMed (original) (raw)

Pharmacology of adapalene

S Michel et al. Br J Dermatol. 1998 Oct.

Abstract

Adapalene, a synthetic retinoid, is a new drug proposed for the treatment of acne patients. Studies on the in vitro and in vivo pharmacology of adapalene have shown that it is very active on cell and tissue proliferation and differentiation. Furthermore, adapalene has anti-inflammatory potential as determined by its anti-AP1 activity. Adapalene interacts selectively with the nuclear receptors RAR beta and RAR gamma, and its activity on proliferation and differentiation can be blocked by a RAR beta-gamma antagonist. Because RAR beta is not expressed in human keratinocytes, the effect of adapalene on the major cell type of the epidermis is certainly mediated by its interaction with RAR gamma. The unique pharmacological properties of adapalene may explain why, when compared to tretinoin, it has an improved therapeutic ratio due to its better tolerance.

PubMed Disclaimer

Similar articles

• Pharmacology and chemistry of adapalene.
  Shroot B, Michel S. Shroot B, et al. J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S96-103. doi: 10.1016/s0190-9622(97)70050-1. J Am Acad Dermatol. 1997. PMID: 9204085 Review.
• Adapalene, a new chemical entity with retinoid activity.
  Bernard BA. Bernard BA. Skin Pharmacol. 1993;6 Suppl 1:61-9. doi: 10.1159/000211165. Skin Pharmacol. 1993. PMID: 8142113 Review.
• A new concept of drug delivery for acne.
  Shroot B, Michel S, Allec J, Chatelus A, Wagner N. Shroot B, et al. Dermatology. 1998;196(1):165-70. doi: 10.1159/000017854. Dermatology. 1998. PMID: 9557255
• Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
  Brogden RN, Goa KE. Brogden RN, et al. Drugs. 1997 Mar;53(3):511-9. doi: 10.2165/00003495-199753030-00010. Drugs. 1997. PMID: 9074847 Review.
• Topical tretinoin or adapalene in acne vulgaris: an overview.
  Jain S. Jain S. J Dermatolog Treat. 2004 Jul;15(4):200-7. doi: 10.1080/09546630410033006. J Dermatolog Treat. 2004. PMID: 15764031 Review.

Cited by

• Enhancement of Efficacy of Retinoids through Enhancing Retinoid-Induced RAR Activity and Inhibiting Hydroxylation of Retinoic Acid, and Its Clinical Efficacy on Photo-Aging.
  Kang S, Lee H, Jun SH, Park SG, Kang NG. Kang S, et al. Pharmaceutics. 2022 Nov 8;14(11):2412. doi: 10.3390/pharmaceutics14112412. Pharmaceutics. 2022. PMID: 36365229 Free PMC article.
• Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction.
  Mehraj U, Mir IA, Hussain MU, Alkhanani M, Wani NA, Mir MA. Mehraj U, et al. Front Oncol. 2022 Jul 6;12:938052. doi: 10.3389/fonc.2022.938052. eCollection 2022. Front Oncol. 2022. PMID: 35875119 Free PMC article.
• Trifarotene: A Novel Therapeutic Option for Acne.
  Naik PP. Naik PP. Dermatol Res Pract. 2022 May 27;2022:1504303. doi: 10.1155/2022/1504303. eCollection 2022. Dermatol Res Pract. 2022. PMID: 35668721 Free PMC article. Review.
• Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes.
  Dreno B, Chavda R, Julia V, Khammari A, Blanchet-Réthoré S, Krishnaswamy JK. Dreno B, et al. Front Med (Lausanne). 2021 Oct 22;8:745822. doi: 10.3389/fmed.2021.745822. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34746181 Free PMC article.
• Synthetic Retinoids Beyond Cancer Therapy.
  Gudas LJ. Gudas LJ. Annu Rev Pharmacol Toxicol. 2022 Jan 6;62:155-175. doi: 10.1146/annurev-pharmtox-052120-104428. Epub 2021 Sep 13. Annu Rev Pharmacol Toxicol. 2022. PMID: 34516292 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database